Clinical Trials Directory

Trials / Active Not Recruiting

Active Not RecruitingNCT07096206

Characteristics and Impacts of X-linked Hypohidrotic Ectodermal Dysplasia (XLHED) in Boys: An Observational International Study

Natural History and Disease Burden of X-linked Hypohidrotic Ectodermal Dysplasia (XLHED): An Observational, Multicentre, International Study (EdeReaLife)

Status
Active Not Recruiting
Phase
Study type
Observational
Enrollment
27 (actual)
Sponsor
Pierre Fabre Medicament · Industry
Sex
Male
Age
0 Years – 11 Years
Healthy volunteers
Not accepted

Summary

This is an observational, multicentre, international study over a 2-year follow-up period. The aim of this study is to understand how XLHED affects the lives of young male patients and their families over time. By studying the natural course of the disease and its impact, the study could improve the understanding of the challenges faced by these patients and their families.

Detailed description

XLHED is a rare genetic condition that affects more severely males. The main symptoms are missing or reduced ability to sweat, leading to a risk of dangerous overheating, as well as few or no teeth and sparse hair. This condition can significantly impact the daily lives of patients and their families. Given the rarity of the disease and the purely descriptive purposes of the study, all eligible patients may be included over a period of approximately 12 months. It is expected to include between 20 and 30 male patients over one year of enrolment in France and Germany. Statistical analysis: will be descriptive with no hypothesis tested. Questionnaires will be completed by the child's parent at inclusion and at 1 and 2 years after the inclusion data

Conditions

Timeline

Start date
2023-07-19
Primary completion
2026-11-19
Completion
2026-11-19
First posted
2025-07-31
Last updated
2025-07-31

Locations

2 sites across 2 countries: France, Germany

Source: ClinicalTrials.gov record NCT07096206. Inclusion in this directory is not an endorsement.